Having trouble accessing articles? Reset your cache.

Peregrine raises $14.3 million

Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) raised $14.3 million from MLV in an at-the-market program. The funds

Read the full 151 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE